Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer-Reference-Cited by-同舟云学术

Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer

Published:2021 Issue:3 Volume:18 Page:285-294
ISSN:1109-6535
Container-title:Cancer Genomics - Proteomics
language:en
Short-container-title:Cancer Genomics Proteomics

Author:

AGIANNITOPOULOS KONSTANTINOS,PEPE GEORGIA,PAPADOPOULOU EIRINI,TSAOUSIS GEORGIOS N.,KAMPOURI STAVROULA,MARAVELAKI SONIA,FASSAS ATHANASSIOS,CHRISTODOULOU CHRISTOS,IOSIFIDOU RODONIKI,KARAGEORGOPOULOU SOFIA,MARKOPOULOS CHRISTOS,NATSIOPOULOS IOANNIS,PAPAZISIS KONSTANTINOS,VASILAKI-ANTONATOU MARIA,VENIZELOS VASSILEIOS,OZMEN VAHIT,TANSAN SUALP,KABAN KERIM,ENIU DAN TUDOR,CHIOREAN ANGELICA,NASIOULAS GEORGE

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Genetics,Molecular Biology,Biochemistry

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing;JAMA Oncology;2023-11-04

2. Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon;The American Journal of Human Genetics;2023-08

3. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing;Cancer Genomics - Proteomics;2023

4. Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer;npj Genomic Medicine;2022-08-25

5. Transcriptome analysis provides critical answers to the “variants of uncertain significance” conundrum;Human Mutation;2022-05-18